| Serial Number | 97106183 |
| Word Mark | EXOTAC |
| Filing Date | Wednesday, November 3, 2021 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, July 30, 2024 |
| Registration Number | 7459469 |
| Registration Date | Tuesday, July 30, 2024 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, May 14, 2024 |
| Goods and Services | Biological preparations for medical or veterinary purposes for the treatment of cancer, metabolic diseases, inflammatory diseases, genetic diseases, infectious diseases, cardiovascular diseases, respiratory diseases, neurological diseases, auto-immune diseases, fibrosis diseases, allergies, skin diseases, endocrine diseases, gastrointestinal diseases, hematologic diseases, diseases and disorders of the immune system, ophthalmic diseases, kidney diseases, and urinary diseases; biochemical preparations for medical or veterinary purposes for the treatment of cancer, metabolic diseases, inflammatory diseases, genetic diseases, infectious diseases, cardiovascular diseases, respiratory diseases, neurological diseases, auto-immune diseases, fibrosis diseases, allergies, skin diseases, endocrine diseases, gastrointestinal diseases, hematologic diseases, diseases and disorders of the immune system, ophthalmic diseases, kidney diseases, and urinary diseases; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; pharmaceuticals featuring drug delivery system, namely, pharmaceutical preparations for the treatment of cancer, metabolic diseases, inflammatory diseases, genetic diseases, infectious diseases, cardiovascular diseases, respiratory diseases, neurological diseases, auto-immune diseases, fibrosis diseases, allergies, skin diseases, endocrine diseases, gastrointestinal diseases, hematologic diseases, diseases and disorders of the immune system, ophthalmic diseases, kidney diseases, urinary diseases; preparations for intracellular drug delivery, namely, drug delivery agents in the form of capsules, tablets, pills, powders, liquids, suspensions, injections, creams, emulsions, gels, liniments, lotions, ointments, pathes, solutions, syrups, aerosols, granules, implants, inhalants, pellets that facilitate the delivery of pharmaceutical preparations; pharmaceuticals for the treatment of immune system disease; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of cellular diseases; chemico-pharmaceutical preparations for the treatment of cancer, metabolic diseases, inflammatory diseases, genetic diseases, infectious diseases, cardiovascular diseases, respiratory diseases, neurological diseases, auto-immune diseases, fibrosis diseases, allergies, skin diseases, endocrine diseases, gastrointestinal diseases, hematologic diseases, diseases and disorders of the immune system, ophthalmic diseases, kidney diseases, and urinary diseases; protein preparations, namely, protein supplements; biotechnological preparations for medical purposes for treatment of cancer, metabolic diseases, inflammatory diseases, genetic diseases, infectious diseases, cardiovascular diseases, respiratory diseases, neurological diseases, auto-immune diseases, fibrosis diseases, allergies, skin diseases, endocrine diseases, gastrointestinal diseases, hematologic diseases, diseases and disorders of the immune system, ophthalmic diseases, kidney diseases, and urinary diseases; reagents for medical use; pharmaceuticals for human purposes for the treatment of cancer, metabolic diseases, inflammatory diseases, genetic diseases, infectious diseases, cardiovascular diseases, respiratory diseases, neurological diseases, auto-immune diseases, fibrosis diseases, allergies, skin diseases, endocrine diseases, gastrointestinal diseases, hematologic diseases, diseases and disorders of the immune system, ophthalmic diseases, kidney diseases, and urinary diseases; biochemical pharmaceuticals for the treatment of cancer, metabolic diseases, inflammatory diseases, genetic diseases, infectious diseases, cardiovascular diseases, respiratory diseases, neurological diseases, auto-immune diseases, fibrosis diseases, allergies, skin diseases, endocrine diseases, gastrointestinal diseases, hematologic diseases, diseases and disorders of the immune system, ophthalmic diseases, kidney diseases, and urinary diseases; biological tissue cultures for medical purposes; diagnostic reagents for medical use; pharmaceuticals for the treatment of cancer, metabolic diseases, inflammatory diseases, genetic diseases, infectious diseases, cardiovascular diseases, respiratory diseases, neurological diseases, auto-immune diseases, fibrosis diseases, allergies, skin diseases, endocrine diseases, gastrointestinal diseases, hematologic diseases, diseases and disorders of the immune system, ophthalmic diseases, kidney diseases, and urinary diseases |
| Goods and Services | Biological preparations, other than for medical or veterinary purposes; biological preparation for use in cell cultures other than for medical or veterinary use; biological preparation for use in the manufacture of pharmaceuticals; biological preparations for use in experiments containing exosomes carrying the desired protein, other than for medical or veterinary use; biochemical preparations for gene recombination for scientific or laboratory purposes; biological tissue cultures, other than for medical or veterinary purposes; cells for scientific or laboratory purposes; biological preparations for scientific or laboratory purposes other than for medical or veterinary use; diagnostic reagents for scientific or research use; diagnostic reagents for use in biological or genetic engineering for scientific or research use and medical laboratory use; reagents for scientific or medical research use; biological preparations for use in biotechnology industry and science, other than for medical purpose; cell growth media for growing cells for use in scientific research; biochemicals for in vitro and in vivo scientific use; reagents for medical research; biological preparation containingexosomes for use in manufacture of cosmetics; protein for use in the manufacture of cosmetics; chemical preparations for use in the manufacture of cosmetics; chemical additives for use in the manufacture of cosmetics; proteins for the food industry |
| Goods and Services | Research and development of technology for biotechnology; development of pharmaceutical preparations and medicines; development of cell therapy products; research and development of new pharmaceuticals; medical research and product development services; research and development of vaccines and medicines; product development in the field of biologics; research of biologics, namely, scientific study and research in the field of biologics; laboratory research in the field of biology; industrial research in the field of biomedical engineering; technological research in the field of cell biology; scientific research in the field of pharmaceuticals; biotechnology research; biological research services; research for medical products; research in the field of chemistry; drug discovery services; biomedical research services; pharmaceutical drug development services |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, November 13, 2021 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, March 14, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, November 13, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | ILIAS Biologics Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Daejeon 34014 KR |
| Party Name | ILIAS Biologics Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Daejeon 34014 KR |
| Party Name | ILIAS Biologics Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Daejeon 34014 KR |
| Event Date | Event Description |
| Saturday, November 6, 2021 | NEW APPLICATION ENTERED |
| Saturday, November 13, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, August 13, 2022 | ASSIGNED TO EXAMINER |
| Sunday, August 21, 2022 | NON-FINAL ACTION WRITTEN |
| Sunday, August 21, 2022 | NON-FINAL ACTION E-MAILED |
| Sunday, August 21, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Saturday, February 18, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Saturday, February 18, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, February 20, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, March 14, 2023 | SUSPENSION LETTER WRITTEN |
| Tuesday, March 14, 2023 | LETTER OF SUSPENSION E-MAILED |
| Tuesday, March 14, 2023 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Monday, September 11, 2023 | SUSPENSION INQUIRY WRITTEN |
| Monday, September 11, 2023 | INQUIRY TO SUSPENSION E-MAILED |
| Monday, September 11, 2023 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
| Saturday, November 18, 2023 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Tuesday, April 9, 2024 | ASSIGNED TO LIE |
| Thursday, April 11, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, April 11, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, April 11, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, April 24, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, May 14, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, May 14, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 30, 2024 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, July 30, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |